Page last updated: 2024-11-03

proxymetacaine and Epilepsy

proxymetacaine has been researched along with Epilepsy in 1 studies

proxymetacaine: RN given refers to parent cpd; structure

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Taleb, A1
Zhou, YP1
Meng, LT1
Zhu, MY1
Zhang, Q1
Naveed, M1
Li, LD1
Wang, P1
Zhou, QG1
Meng, F1
Han, F1

Other Studies

1 other study available for proxymetacaine and Epilepsy

ArticleYear
New application of an old drug proparacaine in treating epilepsy via liposomal hydrogel formulation.
    Pharmacological research, 2021, Volume: 169

    Topics: Animals; Anticonvulsants; Drug Delivery Systems; Electroencephalography; Epilepsy; Hindlimb Suspensi

2021